posted June 22, 2022 07:27 am by AviseAnalytics
(4)
$ACAD Acadia Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company developing small molecule drugs for treating central nervous system disorders, faced a setback at the FDA's
...read more